Committing towards the ongoing national efforts to combat COVID-19, Sunshine Healthcare Lanka Ltd—a fully-owned subsidiary of the diversified conglomerate Sunshine Holdings PLC—donated LabGun Covid-19 PCR (Polymerase chain reaction) test kits to the Ministry of Health by the staff of Sunshine Healthcare. The LabGun COVID-19 new PCR test kits, which are worth Rs. 4.8 million, will further strengthen Sri Lanka’s testing capacity and will be immensely useful in the country’s efforts in dealing with the prevailing situation.
The LabGun COVID-19 PCR kit is manufactured by LabGenomics, a South Korean molecular diagnostics company partnered with Siemens Healthineers, which is represented by Sunshine Healthcare Lanka in Sri Lanka for the distribution of these kits. These PCR kits were used in South Korea largely and helped them to flatten the curve, during their peak period of the COVID-19 pandemic. The key advantage of these PCR kits can be used as a screening and confirmatory assay as separate and can be used independently.
Commenting on this timely donation, Sunshine Healthcare’s Medical Devices Chief Executive Officer T. Sayandhan said, “As the nation’s healthcare front liners work tirelessly to protect every citizen against the COVID-19 outbreak, we understood that the need to strengthen the capacity to test Sri Lankans consistently is significant too. It is in this light that we pledged to provide these LabGun COVID-19 PCR test kits to support the government’s commitment to mitigate this global pandemic through continuous testing. The entire Sunshine Healthcare team is fully committed to supporting this national cause at this time of need.”
Siemens Healthineers AG is a leading medical technology company headquartered in Erlangen, Germany, enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics.
Sunshine Healthcare Lanka (SHL), established in 1967, is the partner of choice for international healthcare companies seeking to grow their business in Sri Lanka, in the areas of pharmaceuticals, medical devices and consumer health products. Sunshine Healthcare is a leading market expansion services provider, with the most extensive specialized healthcare team, with over 300 medical marketing and sales personnel as well as 200 physical distribution personnel. The company offers the local healthcare industry a broad range of customized services from registration to importation, customs clearance, sales, marketing and merchandising, warehousing, physical distribution, invoicing and cash collection. Some of the Sunshine Healthcare partners are 3M Healthcare, Johnson & Johnson Medical Devices, GE Healthcare, Siemens Healthineers, Abbott Laboratories, Zydus Cadila, Glenmark Pharmaceuticals and Novo Nordisk.